References
- WHO. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO report 2005.World Health Organization, (WHO/HTM/TB/2005.349).
- Weyer, K. Tuberculosis in Bangladesh 1996. World Health Organization. 1997.
- van Deun A, Aung KJ, Chowdhury S, Saha S, Pankaj A, Ashraf A, et al. Drug susceptibility of Mycobacterium tuberculosis in a rural area of Bangladesh and its relevance to the national treatment regimens. Int J Tuberc Lung Dis 1999; 3: 143–8
- Mostafa MG, Haque ME, Islam KE, Zaman AMI, Moshlehuman AKM. Study on drug susceptibility of tuberculosis in sputum of a sample of patients in IDCH, Dhaka. Bangladesh Chest and Heart Bulletin 1996; 20: 18–21
- Miah MR, Ali MS, Saleh AA, Sattar H. Primary drug resistance pattern of Mycobacterium tuberculosis in Dhaka, Bangladesh. Bangladesh Med Res Counc Bull 2000; 26: 33–40
- van Deun A, Salim AH, Daru P, Das AP, Aung KJ, Hossain MA, et al. Drug resistance monitoring: combined rates may be the best indicator of programme performance. Int J Tuberc Lung Dis 2004; 8: 23–30
- Zaman K, Rahim Z, Yunus M, Arifeen S, Baqui A, Sack D, et al. Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh. Scand J Infect Dis 2005; 37: 21–6
- Storla, DG, Rahim, Z, Myrvang, B, Bjune, G, Islam, MA, Plettner, S, , et al. Molecular epidemiology of Mycobacterium tuberculosis in Bangladesh. Scandinavian Journal of Infectious Diseases 2006;38:593–6.
- Petroff SA. A new and rapid method for the isolation and culture of tubercle bacilli directly from the sputum and faeces. J Exp Med 1915; 21: 38–42
- Lecoeur HF, Lagrange PH, Truffot-Pernot C, Gheorghiu M, Grosset J. Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice. Clin Exp Immunol 1989; 76: 458–62
- Dahle UR, Sandven P, Heldal E, Mannsaaker T, Caugant DA. Deciphering an outbreak of drug-resistant Mycobacterium tuberculosis. J Clin Microbiol 2003; 41: 67–72
- Pichula K, Szaro A, Janowiec M, Chomenko A, Gerloff W, Hejny M, et al. Comparative studies on detergents: chlorhexidinum gluconicum, ditalan wo hc, sodium-laurylsulfate, laurosept, nekal bx, used for homogenization of diagnostic specimens in the microbiological diagnosis of tuberculosis. Z Erkr Atmungsorgane 1981; 156: 255–66
- Mushtaque A, Chowdhury R. Success with the DOTS strategy. Lancet 1999; 353: 1003–4
- Paramasivan CN, Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004; 120: 377–86
- Phyu S, Lwin T, Ti T, Maung W, Mar WW, Shein SS, Grewal HM. Drug-resistant tuberculosis in Yangon, Myanmar. Scand J Infect Dis 2005; 37: 846–51
- Riantawan P, Punnotok J, Chaisuksuwan R, Pransujarit V. Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the central region of Thailand, 1996. Int J Tuberc Lung Dis 1998; 2: 616–20
- WHO. Report no. 2, Prevalence and Trends. World Health Organization, 2004.
- Sirgel FA, Donald PR, Odhiambo J, Githui W, Umapathy KC, Paramasivan CN, et al. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother 2000; 45: 859–70
- Shimao T. Drug resistance in tuberculosis control. Tubercle 1987; 68: 5–18
- Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int J Tuberc Lung Dis 1998; 2: 10–5
- Traore I, Slosarek M. Survival of mycobacteria in sputum at different temperatures. Czech Med 1981; 4: 203–8
- Ratnam S, Stead FA, Howes M. Simplified acetylcysteine-alkali digestion-decontamination procedure for isolation of mycobacteria from clinical specimens. J Clin Microbiol 1987; 25: 1428–32